Clonal hematopoiesis
Clonal Hematopoiesis is a medical condition characterized by the presence of genetically distinct populations of blood cells that originate from a single progenitor cell. This phenomenon is often associated with aging and is linked to an increased risk of hematological malignancies and cardiovascular disease.
Overview[edit | edit source]
Clonal hematopoiesis is a state in which a single hematopoietic stem cell (HSC) or progenitor cell gives rise to a significant proportion of the blood cell population. This is due to a competitive advantage of the clone over other HSCs, often conferred by somatic mutations. The condition is more common in older individuals and is associated with an increased risk of developing blood cancers and cardiovascular disease.
Causes[edit | edit source]
The exact cause of clonal hematopoiesis is not fully understood. However, it is believed to be due to the accumulation of somatic mutations in hematopoietic stem cells. These mutations can confer a competitive advantage to the mutated cell, allowing it to proliferate more rapidly than normal cells. Some of the most common mutations associated with clonal hematopoiesis include those in the DNMT3A, TET2, and ASXL1 genes.
Clinical Significance[edit | edit source]
Clonal hematopoiesis is often asymptomatic and is usually discovered incidentally during genetic testing for other conditions. However, it is associated with an increased risk of developing hematological malignancies, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic lymphocytic leukemia (CLL).
In addition to its association with blood cancers, clonal hematopoiesis has also been linked to an increased risk of cardiovascular disease. This is thought to be due to the pro-inflammatory effects of some of the mutations associated with the condition.
Treatment[edit | edit source]
There is currently no specific treatment for clonal hematopoiesis. Instead, management focuses on monitoring for the development of hematological malignancies and managing any associated conditions, such as cardiovascular disease.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
